The study examined 180 patients with advanced lung cancer who received a COVID vaccine within 100 days before or after beginning immunotherapy, as well as 704 similar patients who did not. Vaccinated ...

The global respiratory disease vaccine market size was valued at USD 65.72 billion in 2025 and is predicted to hit around USD ...

Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS ...

Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an upda ...

UK MHRA approves zapomeran mRNA Covid-19 vaccine for immunisation of individuals aged 18 years of age and older: United Kingdom Monday, January 5, 2026, 11:00 Hrs [IST] The Medici ...

Researchers found that in mouse models (in a lab), SARS‑CoV‑2 mRNA vaccination triggered strong type I interferon signals, ...

Researchers have used an experimental mRNA therapy to make old immune cells in mice behave as if they were young again, ...

A trio of mRNA molecules could help guard against the harmful effects of aging on immune cells, a study in mice finds.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Kostaive (zapomeran) mRNA COVID-19 ...

As with any medicine, the MHRA will keep the safety and effectiveness of zapomeran under close review. The Medicines and Healthcare products ...

NICE has backed NHS use of natalizumab, a key treatment option that is safe for use in pregnancy, for more patients with ...

Researchers found a way to boost aging immune systems by turning the liver into a temporary source of immune support signals ...